Rayes, N <br/><br/>
Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment?  [electronic resource] 

 -  Transplantation proceedings   
 - 1804 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(00)02688-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Antigens, Viral--blood<br/>Antiviral Agents--administration & dosage<br/>Biomarkers--blood<br/>Case-Control Studies<br/>Cytomegalovirus Infections--drug therapy<br/>Female<br/>Ganciclovir--administration & dosage<br/>Humans<br/>Liver Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Phosphoproteins--blood<br/>Prospective Studies<br/>Viral Matrix Proteins--blood